Cargando…

Kaempferol attenuates liver fibrosis by inhibiting activin receptor–like kinase 5

Liver fibrosis is a common public health problem. Patients with liver fibrosis are more likely to develop cirrhosis, or hepatocellular carcinoma (HCC) as a more serious consequence. Numerous therapeutic approaches have emerged, but the final clinical outcome remains unsatisfactory. Here, we discover...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Taifu, Huang, Shan, Huang, Qianrong, Ming, Zhiyong, Wang, Min, Li, Rongrui, Zhao, Yinnong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714241/ https://www.ncbi.nlm.nih.gov/pubmed/31273920 http://dx.doi.org/10.1111/jcmm.14528

Ejemplares similares

Activin Receptor-Like Kinase 5 Inhibitor Attenuates Fibrosis in Fibroblasts Derived from Peyronie's Plaque
por: Jang, Jin Hyuk, et al.
Publicado: (2012)

Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting
por: Levolger, S., et al.
Publicado: (2019)

The orphan ligand, activin C, signals through activin receptor-like kinase 7
por: Goebel, Erich J, et al.
Publicado: (2022)

Activin–like kinase–3 activity is important for kidney regeneration and reversal of fibrosis
por: Sugimoto, Hikaru, et al.
Publicado: (2012)

Targeting heterotopic ossification by inhibiting activin receptor-like kinase 2 function
por: Shi, Fuli, et al.
Publicado: (2019)

Flavones hydroxylated at 5, 7, 3′ and 4′ ameliorate skin fibrosis via inhibiting activin receptor-like kinase 5 kinase activity
por: Zhang, Yifan, et al.
Publicado: (2019)

An Activin Receptor IA/Activin-Like Kinase-2 (R206H) Mutation in Fibrodysplasia Ossificans Progressiva
por: Herrera-Esparza, Rafael, et al.
Publicado: (2013)

The Activin Receptor, Activin-Like Kinase 4, Mediates Toxoplasma Gondii Activation of Hypoxia Inducible Factor-1
por: Lis, Agnieszka, et al.
Publicado: (2019)

Activin E is a TGFβ ligand that signals specifically through activin receptor-like kinase 7
por: Vestal, Kylie A, et al.
Publicado: (2023)

Activin B promotes the initiation and progression of liver fibrosis
por: Wang, Yan, et al.
Publicado: (2022)

The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology
por: Hardy, Charles L, et al.
Publicado: (2015)

Activin A inhibition attenuates sympathetic neural remodeling following myocardial infarction in rats
por: Hu, Juan, et al.
Publicado: (2018)

Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling
por: Song, Yu, et al.
Publicado: (2023)

Role of activin receptor-like kinase 1 in vascular development and cerebrovascular diseases
por: Hong, Jun-Mou, et al.
Publicado: (2020)

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
por: Lu, Yifei, et al.
Publicado: (2022)

Bioinformatic Analysis of Pathogenic Missense Mutations of Activin Receptor Like Kinase 1 Ectodomain
por: Scotti, Claudia, et al.
Publicado: (2011)

Targeting activin receptor–like kinase 7 ameliorates adiposity and associated metabolic disorders
por: Zhao, Min, et al.
Publicado: (2023)

Antisense-Oligonucleotide Mediated Exon Skipping in Activin-Receptor-Like Kinase 2: Inhibiting the Receptor That Is Overactive in Fibrodysplasia Ossificans Progressiva
por: Shi, SongTing, et al.
Publicado: (2013)

Inhibition of activin A receptor signalling attenuates age-related pathological cardiac remodelling
por: Clavere, Nicolas G., et al.
Publicado: (2022)

Inhibition of Staphylococcus aureus PriA Helicase by Flavonol Kaempferol
por: Huang, Yen-Hua, et al.
Publicado: (2015)

Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders
por: Katagiri, Takenobu, et al.
Publicado: (2021)

Endothelial Activin Receptor-Like Kinase 1 (ALK1) Regulates Myofibroblast Emergence and Peritubular Capillary Stability in the Early Stages of Kidney Fibrosis
por: Martínez-Salgado, Carlos, et al.
Publicado: (2022)

Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis
por: Cunha, Sara I., et al.
Publicado: (2010)

Heterozygous disruption of activin receptor-like kinase 1 is associated with increased arterial pressure in mice
por: González-Núñez, María, et al.
Publicado: (2015)

Activin receptor-like kinase 3: a critical modulator of development and function of mineralized tissues
por: Ruan, Xianchun, et al.
Publicado: (2023)

Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects
Publicado: (1995)

Kaempferol and Kaempferol Rhamnosides with Depigmenting and Anti-Inflammatory Properties
por: Rho, Ho Sik, et al.
Publicado: (2011)

Activation of Activin receptor-like kinases curbs mucosal inflammation and proliferation in chronic rhinosinusitis with nasal polyps
por: Tengroth, Lotta, et al.
Publicado: (2018)

Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis
por: Kasam, Rajesh K, et al.
Publicado: (2020)

The Effects of Kaempferol-Inhibited Autophagy on Osteoclast Formation
por: Kim, Chang-Ju, et al.
Publicado: (2018)

Activin-Like Kinase 2 Functions in Peri-implantation Uterine Signaling in Mice and Humans
por: Clementi, Caterina, et al.
Publicado: (2013)

Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
por: Rodgers, Buel D, et al.
Publicado: (2021)

Selective methylation of kaempferol via benzylation and deacetylation of kaempferol acetates
por: Mei, Qinggang, et al.
Publicado: (2015)

Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
por: Yoon, Jeong-Hwan, et al.
Publicado: (2014)

MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11
por: Siragam, Vinayakumar, et al.
Publicado: (2012)

Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
por: Yoon, Jeong-Hwan, et al.
Publicado: (2013)

Reduction of Activin Receptor-Like Kinase 4 Expression Ameliorates Myocardial Ischemia/Reperfusion Injury through Inhibiting TGFβ Signaling Pathway
por: Chen, Mantian, et al.
Publicado: (2022)

Perspectives of small molecule inhibitors of activin receptor-like kinase in anti-tumor treatment and stem cell differentiation
por: Cui, Xueling, et al.
Publicado: (2019)

Decreased Colonic Activin Receptor-Like Kinase 1 Disrupts Epithelial Barrier Integrity in Patients With Crohn’s Disease
por: Toyonaga, Takahiko, et al.
Publicado: (2020)

Inhibitors of Activin Receptor-like Kinase 5 Interfere with SARS-CoV-2 S-Protein Processing and Spike-Mediated Cell Fusion via Attenuation of Furin Expression
por: Mezger, Maja C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fivbbc1ancvrh1i3jjmbfmgv59